INTELLIPHARMACEUTICS INTERNATIONAL INC. Total Liabilities
INTELLIPHARMACEUTICS INTERNATIONAL INC. had Total Liabilities of $12.53 million as of 2023-02-28, per its 6-K filed 2023-09-26.
Discontinued › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2024-02-06
- 2018-11-30: Liabilities 7.37M CAD.
- 2017-11-30: Liabilities 7.01M CAD.
- 2017-05-31: Liabilities 6.97M CAD.
- 2017-02-28: Liabilities 7.09M CAD.
CAD
| Period end | Liabilities |
|---|---|
| 2018-11-30 | 7.37M CAD 20-F · filed 2019-03-04 |
| 2017-11-30 | 7.01M CAD 20-F · filed 2019-03-04 |
| 2017-05-31 | 6.97M CAD 6-K · filed 2017-07-11 |
| 2017-02-28 | 7.09M CAD 6-K · filed 2017-04-12 |
| 2016-11-30 | 6.86M CAD 20-F · filed 2018-03-01 |
| 2015-11-30 | 5.36M CAD 20-F · filed 2017-02-28 |
USD
| Period end | Liabilities |
|---|---|
| 2023-02-28 | $12.53M 6-K · filed 2023-09-26 |
| 2022-11-30 | $12.01M 20-F/A · filed 2024-02-06 |
| 2022-08-31 | $11.59M 6-K · filed 2022-10-14 |
| 2022-05-31 | $11.74M 6-K · filed 2022-07-21 |
| 2022-02-28 | $10.90M 6-K · filed 2022-04-14 |
| 2021-11-30 | $10.25M 20-F/A · filed 2024-02-06 |
| 2021-08-31 | $9.62M 6-K · filed 2021-10-15 |
| 2021-05-31 | $10.01M 6-K · filed 2021-07-15 |
| 2020-11-30 | $9.70M 20-F/A · filed 2022-05-09 |
| 2020-08-31 | $8.90M 6-K · filed 2020-10-15 |
| 2020-05-31 | $9.37M 6-K · filed 2020-07-15 |
| 2020-02-29 | $8.44M 6-K · filed 2020-05-29 |
| 2019-11-30 | $7.49M 6-K · filed 2020-10-15 |
| 2019-08-31 | $6.57M 6-K · filed 2019-10-11 |
| 2019-05-31 | $6.57M 6-K · filed 2019-07-10 |
| 2019-02-28 | $6.65M 6-K · filed 2019-04-15 |
| 2018-11-30 | $7.37M 20-F · filed 2020-03-30 |
| 2018-08-31 | $10.59M 6-K · filed 2018-10-15 |
| 2018-05-31 | $7.70M 6-K · filed 2018-07-24 |
| 2017-11-30 | $7.01M 6-K · filed 2018-10-15 |
| 2015-11-30 | $5.36M 20-F · filed 2016-03-21 |
| 2014-11-30 | $2.97M 20-F · filed 2016-03-21 |
| 2014-02-28 | $3.56M 6-K · filed 2014-04-14 |
| 2013-11-30 | $10.33M 20-F · filed 2015-02-27 |
| 2012-11-30 | $4.24M 20-F · filed 2014-02-18 |
| 2011-11-30 | $9.34M 20-F/A · filed 2013-02-01 |
| 2010-11-30 | $3.17M 20-F · filed 2012-05-11 |